162 related articles for article (PubMed ID: 17920040)
1. Celecoxib transiently inhibits cellular protein synthesis.
Pyrko P; Kardosh A; Schönthal AH
Biochem Pharmacol; 2008 Jan; 75(2):395-404. PubMed ID: 17920040
[TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
3. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
[TBL] [Abstract][Full Text] [Related]
4. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib inhibits 5-lipoxygenase.
Maier TJ; Tausch L; Hoernig M; Coste O; Schmidt R; Angioni C; Metzner J; Groesch S; Pergola C; Steinhilber D; Werz O; Geisslinger G
Biochem Pharmacol; 2008 Oct; 76(7):862-72. PubMed ID: 18692027
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces.
Arpornmaeklong P; Akarawatcharangura B; Pripatnanont P
Int J Oral Maxillofac Implants; 2008; 23(6):1071-81. PubMed ID: 19216276
[TBL] [Abstract][Full Text] [Related]
9. Stimulated release of arachidonic acid from rat liver cells by celecoxib and indomethacin.
Levine L
Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):31-5. PubMed ID: 11487305
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.
Alloza I; Baxter A; Chen Q; Matthiesen R; Vandenbroeck K
Mol Pharmacol; 2006 May; 69(5):1579-87. PubMed ID: 16467190
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2.
Chen ST; Thomas S; Gaffney KJ; Louie SG; Petasis NA; Schönthal AH
Leuk Res; 2010 Feb; 34(2):250-3. PubMed ID: 19833390
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
[TBL] [Abstract][Full Text] [Related]
13. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells.
Lou J; Fatima N; Xiao Z; Stauffer S; Smythers G; Greenwald P; Ali IU
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1598-606. PubMed ID: 16985019
[TBL] [Abstract][Full Text] [Related]
16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
17. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell].
Wang HJ; Liu XJ; Yang KX; Luo FM; Lou JY; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):757-60. PubMed ID: 17037745
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts.
Chang JK; Li CJ; Liao HJ; Wang CK; Wang GJ; Ho ML
Toxicology; 2009 Apr; 258(2-3):148-56. PubMed ID: 19428934
[TBL] [Abstract][Full Text] [Related]
20. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
Kwak YE; Jeon NK; Kim J; Lee EJ
Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
